doi: 10.1039/c4cc07037b.
Label-free detection of Alzheimer's disease through the ADP3 peptoid recognizing the serum amyloid-beta42 peptide
Affiliations
- PMID: 25418132
- DOI: 10.1039/c4cc07037b
Item in Clipboard
Label-free detection of Alzheimer's disease through the ADP3 peptoid recognizing the serum amyloid-beta42 peptide
Chem Commun (Camb).
.
Abstract
The early diagnosis of Alzheimer's disease (AD) is challenging due to the lack of reliable methods for detecting its biomarkers in the noninvasive biopsies. We used surface plasmon resonance imaging to identify AD based on the detection of amyloid-beta42 in the serum by the ADP3 peptoid.
Similar articles
-
Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease by the Plasma and Serum Amyloid-beta 42 Assay through Highly Sensitive Peptoid Nanosheet Sensor.ACS Appl Mater Interfaces. 2020 Feb 26;12(8):9693-9700. doi: 10.1021/acsami.0c00370. Epub 2020 Feb 12. ACS Appl Mater Interfaces. 2020. PMID: 32013375
-
A shape-code nanoplasmonic biosensor for multiplex detection of Alzheimer's disease biomarkers.Biosens Bioelectron. 2018 Mar 15;101:96-102. doi: 10.1016/j.bios.2017.10.018. Epub 2017 Oct 11. Biosens Bioelectron. 2018. PMID: 29054022
-
Antibody-Mimetic Peptoid Nanosheet for Label-Free Serum-Based Diagnosis of Alzheimer's Disease.Adv Mater. 2017 Aug;29(30). doi: 10.1002/adma.201700057. Epub 2017 Jun 12. Adv Mater. 2017. PMID: 28605073
-
Plasma biomarkers for Alzheimer's disease: much needed but tough to find.Biomark Med. 2012 Aug;6(4):441-54. doi: 10.2217/bmm.12.48. Biomark Med. 2012. PMID: 22917146 Review.
-
Biomarkers of Alzheimer's disease: the present and the future.Rev Neurol (Paris). 2013 Oct;169(10):719-23. doi: 10.1016/j.neurol.2013.07.012. Epub 2013 Sep 7. Rev Neurol (Paris). 2013. PMID: 24021316 Review.
Cited by
-
Peptoids: Smart and Emerging Candidates for the Diagnosis of Cancer, Neurological and Autoimmune Disorders.Int J Mol Sci. 2023 Nov 15;24(22):16333. doi: 10.3390/ijms242216333. Int J Mol Sci. 2023. PMID: 38003529 Free PMC article. Review.
-
Discovery of novel elongator protein 2 inhibitors by compound library screening using surface plasmon resonance.RSC Adv. 2019 Jan 14;9(3):1696-1704. doi: 10.1039/c8ra09640f. eCollection 2019 Jan 9. RSC Adv. 2019. PMID: 35518050 Free PMC article.
-
Recent Advances in the Application Peptide and Peptoid in Diagnosis Biomarkers of Alzheimer's Disease in Blood.Front Mol Neurosci. 2021 Dec 23;14:778955. doi: 10.3389/fnmol.2021.778955. eCollection 2021. Front Mol Neurosci. 2021. PMID: 35002620 Free PMC article. Review.
-
Microfluidic Integrated Organic Electrochemical Transistor with a Nanoporous Membrane for Amyloid-β Detection.ACS Nano. 2021 May 25;15(5):8130-8141. doi: 10.1021/acsnano.0c09893. Epub 2021 Mar 30. ACS Nano. 2021. PMID: 33784064 Free PMC article.
-
Dual-ligand supramolecular nanofibers inspired by the renin-angiotensin system for the targeting and synergistic therapy of myocardial infarction.Theranostics. 2021 Jan 27;11(8):3725-3741. doi: 10.7150/thno.53644. eCollection 2021. Theranostics. 2021. PMID: 33664858 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
